VT
Viridian Therapeutics Inc
🇩🇪XFRA.1S1GermanyHealthcare
€18.80EURdown -0.30 (-1.57%)ClosedEnd of day10:15 PM
Price€18.80-0.30 (-1.57%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US92790C1045
- CUSIP
- Not reported
Company
- Employees
- 252
- Headquarters
- Waltham, United States
- CEO
- Mr. Stephen F. Mahoney J.D., MBA
Market
- Shares outstanding
- 113.3M
- Market cap
- €2.13B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €2.16B
- EPS LTM
- -$3.59
- P/E LTM
- -5.22
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $71.13M+23,220.33%up year on year
- Net income
- -$386.97M-12.47%down year on year
- Gross margin
- 99.22%+66.27%up year on year
- Free cash flow
- -$335.04M-8.22%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.